|
1
|
Crilley P: Intravascular large B-cell
lymphoma: An elusive disease. Oncol Times. 40:16–17. 2018.
|
|
2
|
Shimada K and Kiyoi H: Current progress
and future perspectives of research on intravascular large B-cell
lymphoma. Cancer Sci. 112:3953–3961. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sukswai N, Lyapichev K, Khoury JD and
Medeiros LJ: Diffuse large B-cell lymphoma variants: An update.
Pathology. 52:53–67. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Liu Y, Ma Y, Zhou H, Zhou X and Shao J:
Analysis of clinicopathological features and prognostic factors of
non-Hodgkin's intravascular large B-cell lymphoma. Oncol Lett.
20(43)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Shimada K, Yoshida K, Suzuki Y, Iriyama C,
Inoue Y, Sanada M, Kataoka K, Yuge M, Takagi Y, Kusumoto S, et al:
Frequent genetic alterations in immune checkpoint-related genes in
intravascular large B-cell lymphoma. Blood. 137:1491–1502.
2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Geer M, Roberts E, Shango M, Till BG,
Smith SD, Abbas H, Hill BT, Kaplan J, Barr PM, Caimi P, et al:
Multicentre retrospective study of intravascular large B-cell
lymphoma treated at academic institutions within the United States.
Br J Haematol. 186:255–262. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Shimada K, Yamaguchi M, Atsuta Y, Matsue
K, Sato K, Kusumoto S, Nagai H, Takizawa J, Fukuhara N, Nagafuji K,
et al: Rituximab, cyclophosphamide, doxorubicin, vincristine, and
prednisolone combined with high-dose methotrexate plus intrathecal
chemotherapy for newly diagnosed intravascular large B-cell
lymphoma (PRIMEUR-IVL): A multicentre, single-arm, phase 2 trial.
Lancet Oncol. 21:593–602. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ponnatt TS, Lilley CM and Mirza KM:
Hemophagocytic lymphohistiocytosis. Arch Pathol Laboratory Med.
146:507–519. 2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Teo SCF, Fu EWZ, Bundele MM, Hoe JKM, Ling
LM, Lim MY and Gan JYJ: Intravascular large B-cell lymphoma
associated with sudden stridor arising from thyroid mucormycosis
and concomitant bacterial infection. Ann Acad Med Singap.
51:189–191. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Stonecypher M, Yan Z, Wasik MA and LiVolsi
V: Intravascular large B cell lymphoma presenting as a thyroid
mass. Endocr Pathol. 25:359–360. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Saleem K, Nasrazadani A, Kuang C, Jaitly
V, Ho J, Raptis A, Smith R and Seaman C: Intravascular lymphoma-the
creepy crawler: A case series and brief literature review. Cancer
Diagn Progn. 3:31–37. 2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rea B, Peel RL, Han M, Ohori NP and
Aggarwal N: Intravascular large B-cell lymphoma involving
multinodular goiter and mimicking carcinoma. Int J Surg Pathol.
28:517–518. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Luo B, Chen JM, Liu J, Li WH, Shi YX, Zeng
P, Xie YH and Zhang HF: A case of intravascular large B cell
lymphoma presenting as nodular goiter. Diagn Pathol.
12(64)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Linnik Y, Nicka C, Lansigan F, Loo E and
Liu X: Intravascular Large B-cell lymphoma within a thyroid nodule:
A diagnostic pitfall. Int J Surg Pathol. 26:428–431.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gaul C, Hanisch F, Neureiter D, Behrmann
C, Neundörfer B and Winterholler M: Intravascular lymphomatosis
mimicking disseminated encephalomyelitis and encephalomyelopathy.
Clin Neurol Neurosurg. 108:486–489. 2006.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Katalinić D, Valković T, Lucin K and Rudez
J: Intravascular lymphoma and thyroid gland. Coll Antropol.
30:239–241. 2006.PubMed/NCBI
|
|
17
|
Abe Y, Narita K, Kobayashi H, Kitadate A,
Takeuchi M, Kikuchi Y, Ouchi T, Takeuchi K and Matsue K: Clinical
value of abnormal findings on brain magnetic resonance imaging in
patients with intravascular large B-cell lymphoma. Ann Hematol.
97:2345–2352. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Cox MC, Esposito F, Postorino M, Venditti
A and Di Napoli A: Serum paraprotein is associated with adverse
prognostic factors and outcome, across different subtypes of mature
B-cell malignancies-A systematic review. Cancers (Basel).
15(4440)2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Boonsakan P, Iamsumang W,
Chantrathammachart P, Chayavichitsilp P, Suchonwanit P and Rutnin
S: Prognostic value of concurrent expression of C-MYC and BCL2 in
intravascular large B-cell lymphoma: A 10-year retrospective study.
Biomed Res Int. 2020(1350820)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Gupta A, Jain S, Khurana N and Kakar AK:
Expression of p63 and Bcl-2 in malignant thyroid tumors and their
correlation with other diagnostic immunocytochemical markers. J
Clin Diagn Res. 10:EC04–EC08. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang C, Bo C, Guo L, Yu P, Miao S and Gu
X: BCL2 and hsa-miR-181a-5p are potential biomarkers associated
with papillary thyroid cancer based on bioinformatics analysis.
World J Surg Oncol. 17(221)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhou Z, Liu H, Yang Y, Zhou J, Zhao L,
Chen H, Fei Y, Zhang W, Li M, Zhao Y, et al: The five major
autoimmune diseases increase the risk of cancer: Epidemiological
data from a large-scale cohort study in China. Cancer Commun
(Lond). 42:435–446. 2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Shiboski CH, Shiboski SC, Seror R,
Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H,
Vitali C, Bowman SJ, et al: 2016 American College of
Rheumatology/European League against rheumatism classification
criteria for primary Sjögren's syndrome: A consensus and
data-driven methodology involving three international patient
cohorts. Arthritis Rheumatol. 69:35–45. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kaçar AG and Celkan TT: Hemophagocytic
Lymphohistiocytosis. Balkan Med J. 39:309–317. 2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhang Y, Wang L, Sun J, Wang W, Wei C,
Zhou D and Zhang W: Serum interleukin-10 as a valuable biomarker
for early diagnosis and therapeutic monitoring in intravascular
large B-cell lymphoma. Clin Transl Med. 10(e131)2020.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Vela-ChÁvez T, Adam P, Kremer M, Bink K,
Bacon CM, Menon G, Ferry JA, Fend F, Jaffe ES and
Quintanilla-Martínez L: Cyclin D1 positive diffuse large B-cell
lymphoma is a post-germinal center-type lymphoma without
alterations in theCCND1gene locus. Leuk Lymphoma. 52:458–466.
2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Vanessa S, Caroline B, Alboukadel K, Devin
J, Cartron G, Costes-Martineau V and Moreaux J: An epigenetic
regulator-related score (EpiScore) predicts survival in patients
with diffuse large B cell lymphoma and identifies patients who may
benefit from epigenetic therapy. Oncotarget. 9:19079–19099.
2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Venanzi A, Marra A, Schiavoni G, Milner
SG, Limongello R, Santi A, Pettirossi V, Ultimo S, Tasselli L,
Pucciarini A, et al: Dissecting clonal hematopoiesis in tissues of
patients with classic hodgkin lymphoma. Blood Cancer Discov.
2:216–225. 2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Pagano L, Mele C, Sama MT, Zavattaro M,
Caputo M, De Marchi L, Paggi S, Prodam F, Aimaretti G and Marzullo
P: Thyroid cancer phenotypes in relation to inflammation and
autoimmunity. Front Biosci (Landmark Ed). 23:2267–2282.
2018.PubMed/NCBI View
Article : Google Scholar
|
